Search for dissertations about: "adas"
Showing result 16 - 20 of 39 swedish dissertations containing the word adas.
-
16. Methods and models for safety benefit assessment of advanced driver assistance systems in car-to-cyclist conflicts
Abstract : To help drivers avoid or mitigate the severity of crashes, advanced driver assistance systems (ADAS) can be designed to provide warnings or interventions. Prospective safety assessment of ADAS is important to quantify and optimise their safety benefit. Such safety assessment methods include, for example, virtual simulations and test-track testing. READ MORE
-
17. A Traffic Simulation Modeling Framework for Rural Highways
Abstract : Models based on micro-simulation of traffic flows have proven to be useful tools in the study of various traffic systems. Today, there is a wealth of traffic microsimulation models developed for freeway and urban street networks. The road mileage is however in many countries dominated by rural highways. READ MORE
-
18. Simulation Based Evaluation of Advanced Driver Assistance Systems
Abstract : Road transportation is an essential element of mobility in most countries and we can observe an increasing demand for both goods and passenger traffic. There are however important societal and economical problems related to road transportation in terms of congestions, traffic safety and environmental effects. READ MORE
-
19. Towards an Improved Safety Benefit Assessment for Heavy Trucks - Introduction of a framework for the combination of different data sources
Abstract : Although heavy goods vehicles (HGVs) were only involved in 4.4% out of more than 1 million crashes that occurred on European roads in 2017, their share in crashes with fatal outcome was almost three times larger (12%). READ MORE
-
20. Immunogenicity of biological therapies : frequency, predictability and clinical relevance in chronic inflammatory diseases
Abstract : Over the past three decades, biologic therapies have revolutionised the treatment of chronic inflammatory diseases such as multiple sclerosis (MS), systemic lupus erythematosus (SLE), and anti-neutrophil cytoplasmic antibody (AAV)-associated vasculitis (AAV) and for many, are now a core component of management. However, unlike chemically synthesised smallmolecule drugs, biologicals are larger and are produced using complex processes in or from living organisms, resulting in a propensity to stimulate an unwanted immune response to itself or related proteins. READ MORE